During the past decade, Showa University Karasuyama Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Showa University Karasuyama Hospital" are "Schizophrenia" (4 trials). Many other conditions were trialed in "Showa University Karasuyama Hospital" in a lesser frequency.

Most popular intervention types in "Showa University Karasuyama Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BI 409306 10 mg QD" (1 trials), "BI 409306 100 mg QD" (1 trials), "BI 425809" (1 trials) and "BI 425809 dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Showa University Karasuyama Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Showa University Karasuyama Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Showa University Karasuyama Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Showa University Karasuyama Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".